Cite

    Weycker, D. et al. (2018). Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims. Current medical research and opinion. pp. 1705-1711. [Online].